Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy

As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedin...

Full description

Saved in:
Bibliographic Details
Published in:Mayo Clinic proceedings. Innovations, quality & outcomes quality & outcomes, 2020-12, Vol.4 (6), p.821-825
Main Authors: El Kawkgi, Omar M., Li, Dingfeng, Kotwal, Anupam, Wermers, Robert A.
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedingly rare. We report a case of hypoparathyroidism induced by immune checkpoint drugs, highlighting the need for awareness of this emerging complication.
ISSN:2542-4548
2542-4548
DOI:10.1016/j.mayocpiqo.2020.07.006